MAPT and supranuclear palsy, progressive, 1: Magdalinou and co-authors examined CSF biomarkers, including α-syn, tau, Aβ, and NfL, alongside sAPPα, sAPPβ, and YKL-40, in PSP, CBS, PD, MSA, FTD, AD, and healthy controls [118].